Company Filing History:
Years Active: 2010-2014
Title: Innovations of Pascal Bonaventure
Introduction
Pascal Bonaventure is a notable inventor based in San Diego, CA, who has made significant contributions to the field of pharmacology. He holds 4 patents that focus on innovative therapies for various serotonin-mediated diseases and neurological disorders. His work has the potential to impact the treatment of conditions such as depression and anxiety.
Latest Patents
One of Bonaventure's latest patents involves a combination of a 5-HT7 receptor antagonist and serotonin reuptake inhibitor therapy. This invention aims to provide effective treatment for patients suffering from serotonin-mediated diseases or conditions, such as depression. Another significant patent focuses on substituted piperazines and piperidines as modulators of the neuropeptide Y2 receptor. This invention offers novel non-peptidic NPY Y2 receptor inhibitors that can be useful in treating or preventing a range of disorders, including anxiolytic disorders, neurological disorders, and obesity-related conditions.
Career Highlights
Bonaventure is currently associated with Janssen Pharmaceutica NV, a company known for its commitment to innovative healthcare solutions. His work at this organization has allowed him to explore and develop groundbreaking therapies that address critical health issues.
Collaborations
Throughout his career, Bonaventure has collaborated with esteemed colleagues, including Curt A. Dvorak and Dale A. Rudolph. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Pascal Bonaventure's innovative work in pharmacology highlights his dedication to improving treatment options for various medical conditions. His contributions through patents and collaborations continue to pave the way for advancements in healthcare.